A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
Clinical trial NCT02150499 · TERMINATED
Trial details
- NCT number
- NCT02150499
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.